Tyra Biosciences insider Verjee Rehan purchased 972 shares at $20.58 each on 2026-09-09 under transaction code P. Rehan’s resulting holding was 972 shares, so the purchase represented 100.0% of that holding, giving investors a clear view of the reported insider ownership change.
Key Highlights
- Verjee Rehan’s Tyra Biosciences transaction occurred on 9 September 2026.
- Transaction code P identifies the activity as an open-market purchase.
- The transaction represented about 100.0% of Rehan’s resulting shares holding.
Tyra Biosciences, Inc. (NASDAQ: TYRA) recorded an insider purchase of 972 shares at $20.58 per share. Verjee Rehan’s resulting holding was 972 shares, with the transaction representing about 100.0% of that holding. The transaction took place on 9 September 2026.
Resulting Tyra Biosciences Holding
Rehan’s reported resulting position was 972 shares. The transaction represented about 100.0% of the resulting shares holding. The reported ownership figure applies to Rehan’s resulting holding in Tyra Biosciences, Inc.
FAQs
Q: What did Verjee Rehan buy in Tyra Biosciences?
A: Verjee Rehan purchased 972 shares of Tyra Biosciences, Inc. at $20.58 per share on 9 September 2026. Rehan’s resulting holding was 972 shares.
Q: What is the reported impact of the Tyra Biosciences insider purchase?
A: The transaction resulted in Verjee Rehan holding 972 shares of Tyra Biosciences. The purchase represented about 100.0% of that resulting shares holding.
Q: What does transaction code P mean for TYRA stock?
A: It reports that the transaction involved 972 shares at $20.58 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.